Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Sanofi (Group) [since May 2011]

Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

 

Period Start 2011-05-06 renamed
  Predecessor Sanofi-Aventis (Group)
Product Industry pharmaceutical
Persons Person Hudson, Paul (Sanofi 201909– CEO before Novartis Head Pharma before AstraZeneca + Schering-Plough)
  Person 2 Contamine, Jérôme (Sanofi 2009–201809 CFO RETIRED 9/18)
     
Region Region Paris
  Country France
  Street 174 avenue de France
  City 75635 Paris
  Tel +33-1-5377-4000
    Address record changed: 2020-12-02
     
Basic data Employees I: 50,001 to 100,0 (2021-12-31)
  Currency EUR
  Annual sales 37,761,000,000 (sales, net, consolidated (2021) 2021-12-31)
  Profit 6,279,000,000 (2021-12-31)
  Cash 10,098,000,000 (2021-12-31)
     
    * Document for »About Section«: 
     
   
Record changed: 2024-02-12

Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for Sanofi (Group) [since May 2011]


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top